-
1
-
-
0035897696
-
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
-
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497
-
(2001)
JAMA
, vol.285
, pp. 2486-2497
-
-
-
2
-
-
0032168473
-
Physician noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines
-
Frolkis J.P., Zyzanski S.J., Schwartz J.M., Suhan P.S. Physician noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines. Circulation. 98:1998;851-855
-
(1998)
Circulation
, vol.98
, pp. 851-855
-
-
Frolkis, J.P.1
Zyzanski, S.J.2
Schwartz, J.M.3
Suhan, P.S.4
-
3
-
-
0032496637
-
Primary care practice adherence to National Cholesterol Education Program guidelines for patients with coronary heart disease
-
McBride P., Schrott H.G., Plane M.B., Underbakke G., Brown R.L. Primary care practice adherence to National Cholesterol Education Program guidelines for patients with coronary heart disease. Arch Intern Med. 158:1998;1238-1244
-
(1998)
Arch Intern Med
, vol.158
, pp. 1238-1244
-
-
McBride, P.1
Schrott, H.G.2
Plane, M.B.3
Underbakke, G.4
Brown, R.L.5
-
4
-
-
0034117265
-
Are patients with hyperlipidemia being treated? Investigation of cholesterol treatment practices in an HMO primary care setting
-
Lai L.L., Poblet M., Bello C. Are patients with hyperlipidemia being treated? Investigation of cholesterol treatment practices in an HMO primary care setting. South Med J. 93:2000;283-286
-
(2000)
South Med J
, vol.93
, pp. 283-286
-
-
Lai, L.L.1
Poblet, M.2
Bello, C.3
-
5
-
-
0342424717
-
Bridging the treatment gap
-
Smith S.C. Jr. Bridging the treatment gap. Am J Cardiol. 85:(suppl):2000;3E-7E
-
(2000)
Am J Cardiol
, vol.85
, Issue.SUPPL.
-
-
Smith Jr., S.C.1
-
6
-
-
0035856022
-
Changing the status of drugs from prescription to over-the-counter availability
-
Brass E.P. Changing the status of drugs from prescription to over-the-counter availability. N Engl J Med. 345:2001;810-816
-
(2001)
N Engl J Med
, vol.345
, pp. 810-816
-
-
Brass, E.P.1
-
7
-
-
0032442967
-
Prescription to over-the-counter switch: A regulatory perspective
-
Juhl R.P. Prescription to over-the-counter switch a regulatory perspective. Clin Ther. 20:(suppl):1998;C111-C117
-
(1998)
Clin Ther
, vol.20
, Issue.SUPPL.
-
-
Juhl, R.P.1
-
10
-
-
7044285937
-
The CUSTOM study: A consumer use study of OTC Mevacor
-
(in press)
-
Melin JM, Struble WE, Tipping R, Vassil TC, Reynolds J, Levy SJ, Irvin JD. The CUSTOM study: a consumer use study of OTC Mevacor. Am J Cardiol (in press)
-
Am J Cardiol
-
-
Melin, J.M.1
Struble, W.E.2
Tipping, R.3
Vassil, T.C.4
Reynolds, J.5
Levy, S.J.6
Irvin, J.D.7
-
11
-
-
0032572086
-
Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS
-
Downs J.R., Clearfield M., Weis S., et al. Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels results of AFCAPS/TexCAPS. JAMA. 279:1998;1615-1622
-
(1998)
JAMA
, vol.279
, pp. 1615-1622
-
-
Downs, J.R.1
Clearfield, M.2
Weis, S.3
-
12
-
-
0037490080
-
Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: Systematic review and meta-analysis
-
Law M.R., Wald N.J., Rudnicka A.R. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke systematic review and meta-analysis. BMJ. 326:2003;1423
-
(2003)
BMJ
, vol.326
, pp. 1423
-
-
Law, M.R.1
Wald, N.J.2
Rudnicka, A.R.3
-
13
-
-
0036291921
-
Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors
-
Williams D., Feely J. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors. Clin Pharmacokinet. 41:2002;343-370
-
(2002)
Clin Pharmacokinet
, vol.41
, pp. 343-370
-
-
Williams, D.1
Feely, J.2
-
15
-
-
0036266987
-
Mechanistic studies on metabolic interactions between gemfibrozil and statins
-
Prueksaritanont T., Zhao J.J., Ma B., et al. Mechanistic studies on metabolic interactions between gemfibrozil and statins. J Pharmacol Exp Ther. 301:2002;1042-1051
-
(2002)
J Pharmacol Exp Ther
, vol.301
, pp. 1042-1051
-
-
Prueksaritanont, T.1
Zhao, J.J.2
Ma, B.3
-
16
-
-
0036843479
-
Effects of fibrates on metabolism of statins in human hepatocytes
-
Prueksaritanont T., Tang C., Qiu Y., Mu L., Subramanian R., Lin J.H. Effects of fibrates on metabolism of statins in human hepatocytes. Drug Metab Dispos. 30:2002;1280-1287
-
(2002)
Drug Metab Dispos
, vol.30
, pp. 1280-1287
-
-
Prueksaritanont, T.1
Tang, C.2
Qiu, Y.3
Mu, L.4
Subramanian, R.5
Lin, J.H.6
-
17
-
-
0242288084
-
Label development and the label comprehension study for over-the-counter drugs
-
Brass E., Weintraub M. Label development and the label comprehension study for over-the-counter drugs. Clin Pharmacol Ther. 74:2003;406-412
-
(2003)
Clin Pharmacol Ther
, vol.74
, pp. 406-412
-
-
Brass, E.1
Weintraub, M.2
-
18
-
-
0037166985
-
Long-term persistence in use of statin therapy in elderly patients
-
Benner J.S., Glynn R.J., Mogun H., Neumann P.J., Weinstein M.C., Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 288:2002;455-461
-
(2002)
JAMA
, vol.288
, pp. 455-461
-
-
Benner, J.S.1
Glynn, R.J.2
Mogun, H.3
Neumann, P.J.4
Weinstein, M.C.5
Avorn, J.6
-
19
-
-
0142258290
-
Adherence with statin therapy in secondary prevention of coronary heart disease in Veterans Administration male population
-
Kopjar B., Sales A.E., Pineros S.L., Sun H., Li Y.F., Hedeen A.N. Adherence with statin therapy in secondary prevention of coronary heart disease in Veterans Administration male population. Am J Cardiol. 92:2003;1106-1108
-
(2003)
Am J Cardiol
, vol.92
, pp. 1106-1108
-
-
Kopjar, B.1
Sales, A.E.2
Pineros, S.L.3
Sun, H.4
Li, Y.F.5
Hedeen, A.N.6
-
20
-
-
0032513736
-
Persistence of use of lipid-lowering medications: A cross-national study
-
Avorn J., Monette J., Lacour A., Bohn R.L., Monane M., Mogun H., LeLorier J. Persistence of use of lipid-lowering medications a cross-national study. JAMA. 279:1998;1458-1462
-
(1998)
JAMA
, vol.279
, pp. 1458-1462
-
-
Avorn, J.1
Monette, J.2
Lacour, A.3
Bohn, R.L.4
Monane, M.5
Mogun, H.6
Lelorier, J.7
|